Browse studies

Find your next paid study

66 recruiting studies matching your filters

A Phase 1, Randomized, Placebo-Controlled, First-in-Human, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered KT-579 in Healthy Adult Participants

This is a first-in-human study to evaluate safety and tolerability, pharmacokinetics, and pharmacodynamics of single and multiple dose levels of KT-579 in heal…

Healthy Participants

Estimated

~$10 – $8,750

Kymera Therapeutics, Inc.NCT07412288

SPRINT: Sparking Potential, Revealing Infant Neurocognitive Traits

This research focuses on the long-term cognitive development of children, including healthy infants and those who had a perinatal brain injury. As part of this…

Perinatal Brain InjuryHealthy Participants

Estimated

~$10 – $750

University of Wisconsin, MadisonNCT07390136

Early Biomarkers Study for Prediction of Executive Dysfunction and Cognitive Outcomes Among Infants With Prior Neonatal Brain Injury

This research focuses on the long-term cognitive development of children, including healthy infants and those who had a perinatal brain injury. As part of this…

HIE - Hypoxic - Ischemic EncephalopathyPerinatal Anoxic-ischemic Brain InjuryPremature Birth+1 more

Estimated

~$10 – $750

University of Wisconsin, MadisonNCT07413900

Observational

Effects of Fresh Mango as a Sugar Substitute Within High and Low Glycemic Breakfasts on Postprandial Glucose and Insulin

Large blood sugar and insulin increases after meals high in table sugar are related to risk for diabetes and heart disease. Additionally, large increases in bl…

Healthy Participants

Estimated

~$10 – $6,250

Ball State UniversityNCT07045051

Observational

Comparing Prebiotic Fiber Supplements for Gut Health and Digestive Comfort

This study compares three dietary fiber supplements - LOAM prebiotic fiber, inulin, and a cellulose placebo - to evaluate their effects on intestinal gas produ…

Healthy Participants

Estimated

~$10 – $8,750

Ventoscity LLCNCT07525180

Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals

Pulmonary arterial hypertension (PAH) is a severe disease with a delayed diagnosis and markedly elevated mortality. High-risk populations, such as those with k…

Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionUnaffected Mutation Carriers: Healthy Participants With a Known BMPR2 Gene Mutation and Normal Pulmonary Pressure and RV Function on Echo+1 more

Estimated

~$10 – $750

Vanderbilt University Medical CenterNCT05584722